PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
01-Jun-2021 EULAR 2021: New Data from UCB’s Rheumatology Portfolio Demonstrates Real World Value for Patients with axSpA, PsA, and Women of Childbearing Age UCB
01-Jun-2021 87% of Top 300 Pharma Companies in Europe and US have a Poor Digital Culture that Inhibits Innovation Aspen Technology
01-Jun-2021 COREX Logistics opens Kazakhstan office COREX Logistics
01-Jun-2021 Biotest AG: Ad-hoc RELEASE Announcement according to Article 17 European Market Abuse Regulation (MAR) Biotest AG
01-Jun-2021 Cytel Calls for Statistical Innovation to be Mobilized for Global Health Challenges Cytel Inc.
01-Jun-2021 APEIRON Biologics Announces Changes to Management and Supervisory Boards APEIRON Biologics AG
01-Jun-2021 M1 Kliniken AG publishes figures for the 1st quarter of 2021: successful start to 2021 with significant increase in revenues and earnings in both business segments M1 Kliniken AG
01-Jun-2021 DEFENCE THERAPEUTICS ADVANCES IN PRE-CLINICAL TESTING OF ITS INFECTIOUS DISEASE VACCINE PROGRAM Defence Therapeutics Inc.
01-Jun-2021 Polyphor's balixafortide demonstrates consistent dual action anti-viral and anti-inflammatory activity in COVID-19 preclinical trials Polyphor AG
31-May-2021 IGEA disclosed its Annual Report 2020 IGEA Pharma N.V.
31-May-2021 Sports Supplements Market Size, Share Report 2021 Shipments, Price, Revenue and Gross Profit till 2026 With Impact of COVID-19 Analytical Research Cognizance
31-May-2021 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Reschedules Reporting of 1st Quarter 2021 and Provides Update for Annual General Meeting of Shareholders Vivoryon Therapeutics N.V.
31-May-2021 Top 50 Pharmaceutical Contract Manufacturing Organisations Visiongain
31-May-2021 Registration is open for SMi’s 2nd Annual Next Generation Pharmaceutical Cleanroom SMi Group
31-May-2021 Vita 34 publishes figures for the first quarter of 2021 Vita 34 AG
31-May-2021 Vita 34 AG signs Business Combination Agreement with Polski Bank Komórek Macierzystych S.A. Vita 34 AG
31-May-2021 Vita 34 AG: Vita 34 AG and Warsaw-listed Polski Bank Komórek Macierzystych S.A. sign business combination agreement for potential combination via a share exchange Vita 34 AG
31-May-2021 HAEMATO AG with strong start to the year: EBIT rises in Q1 by 350 % to EUR 2.4 million and revenues by 22 % to EUR 73.9 million. HAEMATO AG
28-May-2021 APONTIS PHARMA AG: Notification on the implementation of stabilization measures APONTIS PHARMA AG
28-May-2021 Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting Cosmo Pharmaceuticals N.V.